Stock Screener · Library
NURIX THERAPEUTICS, INC. financial statement history
Source-linked financial facts for NURIX THERAPEUTICS, INC. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-11-30 | 476771000 | USD | 2023-02-09 | 2022 / FY | us-gaap:Assets | 10-K · 0001549595-23-000021 |
| As of 2022-11-30 | 416759000 | USD | 2024-02-15 | 2023 / FY | us-gaap:Assets | 10-K · 0001549595-24-000025 |
| As of 2023-11-30 | 355598000 | USD | 2025-01-28 | 2024 / FY | us-gaap:Assets | 10-K · 0001549595-25-000016 |
| As of 2024-11-30 | 669343000 | USD | 2026-01-28 | 2025 / FY | us-gaap:Assets | 10-K · 0001549595-26-000016 |
| As of 2025-11-30 | 688135000 | USD | 2026-01-28 | 2025 / FY | us-gaap:Assets | 10-K · 0001549595-26-000016 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-11-30 | 311118000 | USD | 2023-02-09 | 2022 / FY | us-gaap:AssetsCurrent | 10-K · 0001549595-23-000021 |
| As of 2022-11-30 | 318449000 | USD | 2024-02-15 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001549595-24-000025 |
| As of 2023-11-30 | 295503000 | USD | 2025-01-28 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0001549595-25-000016 |
| As of 2024-11-30 | 619387000 | USD | 2026-01-28 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001549595-26-000016 |
| As of 2025-11-30 | 606819000 | USD | 2026-01-28 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001549595-26-000016 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-11-30 | 80506000 | USD | 2023-02-09 | 2022 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001549595-23-000021 |
| As of 2022-11-30 | 64474000 | USD | 2025-01-28 | 2024 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001549595-25-000016 |
| As of 2023-11-30 | 54627000 | USD | 2026-01-28 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001549595-26-000016 |
| As of 2024-11-30 | 109997000 | USD | 2026-01-28 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001549595-26-000016 |
| As of 2025-11-30 | 246960000 | USD | 2026-01-28 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001549595-26-000016 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-11-30 | 11340000 | USD | 2023-02-09 | 2022 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001549595-23-000021 |
| As of 2022-11-30 | 17163000 | USD | 2024-02-15 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001549595-24-000025 |
| As of 2023-11-30 | 16808000 | USD | 2025-01-28 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001549595-25-000016 |
| As of 2024-11-30 | 17757000 | USD | 2026-01-28 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001549595-26-000016 |
| As of 2025-11-30 | 22490000 | USD | 2026-01-28 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001549595-26-000016 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-11-30 | 134469000 | USD | 2023-02-09 | 2022 / FY | us-gaap:Liabilities | 10-K · 0001549595-23-000021 |
| As of 2022-11-30 | 113063000 | USD | 2024-02-15 | 2023 / FY | us-gaap:Liabilities | 10-K · 0001549595-24-000025 |
| As of 2023-11-30 | 155105000 | USD | 2025-01-28 | 2024 / FY | us-gaap:Liabilities | 10-K · 0001549595-25-000016 |
| As of 2024-11-30 | 142350000 | USD | 2026-01-28 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001549595-26-000016 |
| As of 2025-11-30 | 149388000 | USD | 2026-01-28 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001549595-26-000016 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-11-30 | 66258000 | USD | 2023-02-09 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001549595-23-000021 |
| As of 2022-11-30 | 70655000 | USD | 2024-02-15 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001549595-24-000025 |
| As of 2023-11-30 | 86958000 | USD | 2025-01-28 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001549595-25-000016 |
| As of 2024-11-30 | 95854000 | USD | 2026-01-28 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001549595-26-000016 |
| As of 2025-11-30 | 86471000 | USD | 2026-01-28 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001549595-26-000016 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-11-30 | 342302000 | USD | 2025-01-28 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0001549595-25-000016 |
| As of 2022-11-30 | 303696000 | USD | 2026-01-28 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001549595-26-000016 |
| As of 2023-11-30 | 200493000 | USD | 2026-01-28 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001549595-26-000016 |
| As of 2024-11-30 | 526993000 | USD | 2026-01-28 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001549595-26-000016 |
| As of 2025-11-30 | 538747000 | USD | 2026-01-28 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001549595-26-000016 |
Revenue
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2020-12-01 to 2021-11-30 | 29750000 | USD | 2023-02-09 | 2022 / FY | us-gaap:Revenues | 10-K · 0001549595-23-000021 |
| 2021-12-01 to 2022-11-30 | 38627000 | USD | 2025-01-28 | 2024 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001549595-25-000016 |
| 2022-12-01 to 2023-11-30 | 76987000 | USD | 2026-01-28 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001549595-26-000016 |
| 2023-12-01 to 2024-11-30 | 54549000 | USD | 2026-01-28 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001549595-26-000016 |
| 2024-12-01 to 2025-11-30 | 83980000 | USD | 2026-01-28 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001549595-26-000016 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2020-12-01 to 2021-11-30 | 116434000 | USD | 2023-02-09 | 2022 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001549595-23-000021 |
| 2021-12-01 to 2022-11-30 | 184497000 | USD | 2025-01-28 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001549595-25-000016 |
| 2022-12-01 to 2023-11-30 | 189148000 | USD | 2026-01-28 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001549595-26-000016 |
| 2023-12-01 to 2024-11-30 | 221632000 | USD | 2026-01-28 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001549595-26-000016 |
| 2024-12-01 to 2025-11-30 | 316903000 | USD | 2026-01-28 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001549595-26-000016 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2020-12-01 to 2021-11-30 | -117886000 | USD | 2023-02-09 | 2022 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001549595-23-000021 |
| 2021-12-01 to 2022-11-30 | -183867000 | USD | 2025-01-28 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001549595-25-000016 |
| 2022-12-01 to 2023-11-30 | -155063000 | USD | 2026-01-28 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001549595-26-000016 |
| 2023-12-01 to 2024-11-30 | -213027000 | USD | 2026-01-28 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001549595-26-000016 |
| 2024-12-01 to 2025-11-30 | -285666000 | USD | 2026-01-28 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001549595-26-000016 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2020-12-01 to 2021-11-30 | -117194000 | USD | 2023-02-09 | 2022 / FY | us-gaap:NetIncomeLoss | 10-K · 0001549595-23-000021 |
| 2021-12-01 to 2022-11-30 | -180360000 | USD | 2025-01-28 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0001549595-25-000016 |
| 2022-12-01 to 2023-11-30 | -143948000 | USD | 2026-01-28 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001549595-26-000016 |
| 2023-12-01 to 2024-11-30 | -193569000 | USD | 2026-01-28 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001549595-26-000016 |
| 2024-12-01 to 2025-11-30 | -264457000 | USD | 2026-01-28 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001549595-26-000016 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2020-12-01 to 2021-11-30 | -2.73 | USD/shares | 2023-02-09 | 2022 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001549595-23-000021 |
| 2021-12-01 to 2022-11-30 | -3.71 | USD/shares | 2025-01-28 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001549595-25-000016 |
| 2022-12-01 to 2023-11-30 | -2.65 | USD/shares | 2026-01-28 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001549595-26-000016 |
| 2023-12-01 to 2024-11-30 | -2.88 | USD/shares | 2026-01-28 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001549595-26-000016 |
| 2024-12-01 to 2025-11-30 | -3.05 | USD/shares | 2026-01-28 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001549595-26-000016 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2020-12-01 to 2021-11-30 | -84365000 | USD | 2023-02-09 | 2022 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001549595-23-000021 |
| 2021-12-01 to 2022-11-30 | -159807000 | USD | 2025-01-28 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001549595-25-000016 |
| 2022-12-01 to 2023-11-30 | -81365000 | USD | 2026-01-28 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001549595-26-000016 |
| 2023-12-01 to 2024-11-30 | -172584000 | USD | 2026-01-28 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001549595-26-000016 |
| 2024-12-01 to 2025-11-30 | -249465000 | USD | 2026-01-28 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001549595-26-000016 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2020-12-01 to 2021-11-30 | 5661000 | USD | 2023-02-09 | 2022 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001549595-23-000021 |
| 2021-12-01 to 2022-11-30 | 12244000 | USD | 2025-01-28 | 2024 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001549595-25-000016 |
| 2022-12-01 to 2023-11-30 | 8401000 | USD | 2026-01-28 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001549595-26-000016 |
| 2023-12-01 to 2024-11-30 | 9273000 | USD | 2026-01-28 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001549595-26-000016 |
| 2024-12-01 to 2025-11-30 | 14002000 | USD | 2026-01-28 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001549595-26-000016 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1549595
- Ticker in native snapshot
- NRIX
- Reported numeric facts
- 70
- Units present
- USD · USD/shares